AKI-话题@MedSci

#AKI#

70篇内容 | 2800人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1341111, encodeId=3e60134111186, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=JAMA Pediatr：万古霉素联合一种药竟会增加住院儿童AKI风险！, objectType=article, longId=126994, objectId=c3d3126994f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3d3126994f0, replyNumber=0, likeNumber=61, createdTime=2018-01-21, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3d3126994f0, moduleTitle=JAMA Pediatr：万古霉素联合一种药竟会增加住院儿童AKI风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3d3126994f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341110, encodeId=114f134111065, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=Crit Care Med：万古霉素联合哌拉西林-他唑巴坦增加成人AKI风险？, objectType=article, longId=125959, objectId=55db1259598d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55db1259598d, replyNumber=0, likeNumber=90, createdTime=2018-01-10, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55db1259598d, moduleTitle=Crit Care Med：万古霉素联合哌拉西林-他唑巴坦增加成人AKI风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55db1259598d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341109, encodeId=be4e134110977, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=Crit Care：ICU中AKI患者开始肾脏替代治疗的时机和慢性肾脏病的长期风险如何？, objectType=article, longId=125050, objectId=cd8f12505041, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd8f12505041, replyNumber=0, likeNumber=67, createdTime=2017-12-31, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd8f12505041, moduleTitle=Crit Care：ICU中AKI患者开始肾脏替代治疗的时机和慢性肾脏病的长期风险如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd8f12505041)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341108, encodeId=e11a134110852, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=JASN：AKI住院后死亡原因分析！, objectType=article, longId=123654, objectId=85a412365418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85a412365418, replyNumber=0, likeNumber=83, createdTime=2017-12-18, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85a412365418, moduleTitle=JASN：AKI住院后死亡原因分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85a412365418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341107, encodeId=08bc134110e11, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=J Behav Decis Making：吃亏不仅有精神现报而且有物质后报, objectType=article, longId=122891, objectId=8ad7122891d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ad7122891d9, replyNumber=0, likeNumber=52, createdTime=2017-12-11, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad7122891d9, moduleTitle=J Behav Decis Making：吃亏不仅有精神现报而且有物质后报, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ad7122891d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341106, encodeId=e205134110614, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=Diabetes Obes Metab：导致AKI的疾病能使用二甲双胍吗？, objectType=article, longId=122422, objectId=2c401224220d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c401224220d, replyNumber=0, likeNumber=74, createdTime=2017-12-07, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c401224220d, moduleTitle=Diabetes Obes Metab：导致AKI的疾病能使用二甲双胍吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c401224220d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341105, encodeId=d4b81341105c9, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=JASN：AKI危重患者早期RRT的长期临床结局分析！, objectType=article, longId=122088, objectId=2d3412208805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d3412208805, replyNumber=0, likeNumber=64, createdTime=2017-12-04, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d3412208805, moduleTitle=JASN：AKI危重患者早期RRT的长期临床结局分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d3412208805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341104, encodeId=30ba1341104e1, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=NEJM：碳酸氢钠和乙酰半胱氨酸对造影后AKI的预防效果如何？, objectType=article, longId=120053, objectId=e6cf120053b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6cf120053b5, replyNumber=0, likeNumber=74, createdTime=2017-11-16, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6cf120053b5, moduleTitle=NEJM：碳酸氢钠和乙酰半胱氨酸对造影后AKI的预防效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6cf120053b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341103, encodeId=7d3213411038d, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=SCI REP：非心血管手术后AKI患者的住院死亡率和危险因素分析！, objectType=article, longId=117447, objectId=944e11e447df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=944e11e447df, replyNumber=0, likeNumber=75, createdTime=2017-10-26, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=944e11e447df, moduleTitle=SCI REP：非心血管手术后AKI患者的住院死亡率和危险因素分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=944e11e447df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341102, encodeId=e70e1341102e7, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=Crit Care：循环可溶性Fas水平（sCD95）与非恢复型AKI的发生风险相关！, objectType=article, longId=109194, objectId=e8d71091943f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8d71091943f, replyNumber=0, likeNumber=79, createdTime=2017-08-20, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8d71091943f, moduleTitle=Crit Care：循环可溶性Fas水平（sCD95）与非恢复型AKI的发生风险相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8d71091943f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341101, encodeId=ed8f134110141, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=重复 J Am Heart Assoc：急诊血管成形术后AKI 造影剂是罪魁祸首？, objectType=article, longId=107973, objectId=bbc210e973e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbc210e973e3, replyNumber=0, likeNumber=66, createdTime=2017-08-09, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbc210e973e3, moduleTitle=重复 J Am Heart Assoc：急诊血管成形术后AKI 造影剂是罪魁祸首？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbc210e973e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341100, encodeId=e2d7134110014, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=Arthritis Rheumatol：ICU患者碘对比剂的使用是否导致PC-AKI？, objectType=article, longId=107252, objectId=80ea10e2522a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80ea10e2522a, replyNumber=0, likeNumber=69, createdTime=2017-08-02, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80ea10e2522a, moduleTitle=Arthritis Rheumatol：ICU患者碘对比剂的使用是否导致PC-AKI？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80ea10e2522a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341099, encodeId=30fe134109960, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=JASN:AKI的亚型由转录程序确定？, objectType=article, longId=103432, objectId=987b103432fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=987b103432fe, replyNumber=0, likeNumber=55, createdTime=2017-06-28, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=987b103432fe, moduleTitle=JASN:AKI的亚型由转录程序确定？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=987b103432fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341098, encodeId=ccd9134109817, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=Lancet：生物制剂tildrakizumab：牛皮癣“克星”，治疗效果超神奇！, objectType=article, longId=100984, objectId=0b2d100984ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b2d100984ce, replyNumber=0, likeNumber=82, createdTime=2017-06-09, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b2d100984ce, moduleTitle=Lancet：生物制剂tildrakizumab：牛皮癣“克星”，治疗效果超神奇！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b2d100984ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341097, encodeId=6799134109ead, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=生物制剂tildrakizumab：牛皮癣“克星”, objectType=article, longId=101036, objectId=ea8210103664, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea8210103664, replyNumber=0, likeNumber=47, createdTime=2017-06-09, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea8210103664, moduleTitle=生物制剂tildrakizumab：牛皮癣“克星”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea8210103664)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341096, encodeId=4f5b13410963e, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=KIDNEY INT：流行病学研究表明AKI的发病率并没有增加！, objectType=article, longId=99308, objectId=5cf29930831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cf29930831, replyNumber=0, likeNumber=66, createdTime=2017-05-23, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cf29930831, moduleTitle=KIDNEY INT：流行病学研究表明AKI的发病率并没有增加！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cf29930831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341095, encodeId=bed4134109565, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=KIDNEY INT：没有进行AKI干预的PPI使用者长期肾脏预后如何？, objectType=article, longId=89739, objectId=14f989e39fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14f989e39fb, replyNumber=0, likeNumber=68, createdTime=2017-02-24, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14f989e39fb, moduleTitle=KIDNEY INT：没有进行AKI干预的PPI使用者长期肾脏预后如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14f989e39fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341094, encodeId=d5bc134109484, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=TREAKISYM获批成为低度B细胞非霍奇金淋巴瘤和套细胞淋巴瘤抗癌剂, objectType=article, longId=87833, objectId=1fe48e83325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fe48e83325, replyNumber=0, likeNumber=64, createdTime=2017-01-21, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fe48e83325, moduleTitle=TREAKISYM获批成为低度B细胞非霍奇金淋巴瘤和套细胞淋巴瘤抗癌剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fe48e83325)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341093, encodeId=b23c1341093ee, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险, objectType=article, longId=83187, objectId=96138318e28, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96138318e28, replyNumber=0, likeNumber=80, createdTime=2016-11-29, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96138318e28, moduleTitle=JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96138318e28)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1341092, encodeId=37d813410928c, content=<a href='/topic/show?id=b97e223562' target=_blank style='color:#2F92EE;'>#AKI#</a>, objectTitle=JACC：Canakinumab对动脉粥样硬化患者的血管结构或功能无显著影响, objectType=article, longId=79950, objectId=078fe9950a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=078fe9950a5, replyNumber=0, likeNumber=61, createdTime=2016-10-14, rootId=0, userName=ms4468361851264128, userId=f7482500171, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=078fe9950a5, moduleTitle=JACC：Canakinumab对动脉粥样硬化患者的血管结构或功能无显著影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=078fe9950a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

AKI

2020-05-29

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

JAMA Pediatr：万古霉素联合一种药竟会增加住院儿童AKI风险！

2018-01-21

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

Crit Care Med：万古霉素联合哌拉西林-他唑巴坦增加成人AKI风险？

2018-01-10

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

Crit Care：ICU中AKI患者开始肾脏替代治疗的时机和慢性肾脏病的长期风险如何？

2017-12-31

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

JASN：AKI住院后死亡原因分析！

2017-12-18

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

J Behav Decis Making：吃亏不仅有精神现报而且有物质后报

2017-12-11

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

Diabetes Obes Metab：导致AKI的疾病能使用二甲双胍吗？

2017-12-07

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

JASN：AKI危重患者早期RRT的长期临床结局分析！

2017-12-04

智慧医人 (审核中...)

前往app查看评论内容

#AKI#

NEJM：碳酸氢钠和乙酰半胱氨酸对造影后AKI的预防效果如何？

2017-11-16

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

SCI REP：非心血管手术后AKI患者的住院死亡率和危险因素分析！

2017-10-26

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

Crit Care：循环可溶性Fas水平（sCD95）与非恢复型AKI的发生风险相关！

2017-08-20

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

重复 J Am Heart Assoc：急诊血管成形术后AKI 造影剂是罪魁祸首？

2017-08-09

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

Arthritis Rheumatol：ICU患者碘对比剂的使用是否导致PC-AKI？

2017-08-02

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

JASN:AKI的亚型由转录程序确定？

2017-06-28

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

Lancet：生物制剂tildrakizumab：牛皮癣“克星”，治疗效果超神奇！

2017-06-09

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

生物制剂tildrakizumab：牛皮癣“克星”

2017-06-09

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

KIDNEY INT：流行病学研究表明AKI的发病率并没有增加！

2017-05-23

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

KIDNEY INT：没有进行AKI干预的PPI使用者长期肾脏预后如何？

2017-02-24

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

TREAKISYM获批成为低度B细胞非霍奇金淋巴瘤和套细胞淋巴瘤抗癌剂

2017-01-21

hb2008ye (审核中...)

前往app查看评论内容

#AKI#

JACC：达比加群可降低亚洲非瓣膜性房颤患者的AKI风险

2016-11-29

ms4468361851264128 (审核中...)

前往app查看评论内容

#AKI#

JACC：Canakinumab对动脉粥样硬化患者的血管结构或功能无显著影响

2016-10-14

科室
- - 订阅+
  - 更多科室
工具
服务